Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
ANI Pharmaceuticals $316.25 million convertible notes offering
We advised ANI Pharmaceuticals on the offering
Penumbra $100 million accelerated share repurchase
We advised Penumbra on the ASR transaction
Walgreens Boots Alliance $750 million notes offering
We advised Walgreens Boots Alliance on its debt offering
Precigen $34 million follow-on offering
We advised Precigen on the SEC-registered offering
Toyota Motor Credit $2.5 billion notes offering
We advised Toyota Motor Credit on the SEC-registered notes offering
Allegro MicroSystems repurchase of 39 million shares held by Sanken Electric
We advised Allegro on the share repurchase, equity offering and incremental and refinancing credit facilities
Morgan Stanley $1 billion preferred stock offering
We advised Morgan Stanley on its SEC-registered offering
AC Immune $80 million at-the-market offering
We advised AC Immune on the offering
Banco Santander $1.5 billion Tier 1 capital securities offering
We advised Banco Santander on its SEC-registered offering of contingent convertible securities
Aptiv $3 billion accelerated share repurchase
We advised Aptiv on the ASR transactions